Article
Development and validation of LRP1B mutation-associated prognostic model for hepatocellular carcinoma.
Bioscience reports - 30 Sept 2021
Xu Jian, Shen Xiaomin, Zhang Bo, Su Rui, Cui Mingxuan, Yan Lihua, Cao Yu
Abstract excerpt
PURPOSE: To develop a lipoprotein receptor-related protein 1B (LRP1B) gene mutation-based prognostic model for hepatocellular carcinoma (HCC) patients risk prediction. METHODS: The LRP1B gene mutation rate was calculated from HCC patient samples. Meanwhile, differentially expressed genes according to LRP1B mutant were screened out for prognostic model establishment. Based on this innovative model, HCC patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
